One vs two stitch devices for TAVR valve replacement
Part of Heart & circulation clinical trials.
This study compares using one versus two special stitch devices to close the artery after a TAVR procedure. It helps doctors learn which way works better to prevent bleeding or complications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for a TAVR valve replacement through the leg artery
- Your doctor has decided you are a good candidate for the TAVR procedure
- The artery in your leg is suitable for closing with a stitch device
- You do not have an active infection or bleeding disorder
- You are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a heart valve replacement procedure called TAVI can be safely done at heart centers that do not have a full heart surgery team available onsite. It is for people with severe narrowing of the aortic valve who are already planned for TAVI through the leg artery.
This trial compares two approaches for replacing a tight aortic heart valve (TAVI) through a leg artery: doing it with or without a routine check of your heart's arteries (coronary angiogram). If you have severe aortic stenosis and are scheduled for TAVI, this study helps find out whether skipping the artery check is safe and effective.
This trial compares using one versus two Perclose devices to close the large hole in the leg after a TAVR procedure. It aims to find which method works better to prevent bleeding and other complications.
This study compares two ways of closing the large artery in the leg after a TAVI procedure. It aims to see which method is safer and works better for patients.
This trial compares two ways to treat a failing aortic valve that was replaced with a tissue valve during surgery: another surgical replacement or a less invasive catheter-based valve-in-valve procedure. It is for people with low to intermediate surgical risk who are between 18 and 75 years old.
This study tests a new device called ShortCut to help doctors safely replace a failing bioprosthetic heart valve (a valve that was placed in your heart previously) using a minimally invasive procedure. The ShortCut is designed to protect your coronary arteries—the vessels that supply blood to your heart—during this valve replacement.
Hear when a new Severe Aortic Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.